<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) mostly develops from a variety of <z:mpath ids='MPATH_491'>polyps</z:mpath> following mainly three different molecular pathways: <z:mp ids='MP_0008866'>chromosomal instability</z:mp> (CIN), microsatellite instability (MSI) and CpG island methylation (CIMP) </plain></SENT>
<SENT sid="1" pm="."><plain><z:mpath ids='MPATH_491'>Polyps</z:mpath> are classified histologically as conventional <z:mpath ids='MPATH_270'>adenomas</z:mpath>, <z:mpath ids='MPATH_140'>hyperplastic polyps</z:mpath>, sessile serrated <z:mpath ids='MPATH_270'>adenomas</z:mpath>/<z:mpath ids='MPATH_491'>polyps</z:mpath> (SSA/P) and traditional serrated <z:mpath ids='MPATH_270'>adenomas</z:mpath> (TSA) </plain></SENT>
<SENT sid="2" pm="."><plain>However, the association of these <z:mpath ids='MPATH_491'>polyps</z:mpath> with the different types of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> and the underlying genetic and epigenetic aberrations has yet to be resolved </plain></SENT>
<SENT sid="3" pm="."><plain>In order to address this question we analyzed 140 tumors and 20 matched mucosae by array comparative genomic hybridization, by sequence analysis of the oncogenes BRAF, KRAS, PI3K3CA and by methylation arrays </plain></SENT>
<SENT sid="4" pm="."><plain>MSI was tested indirectly by immunohistochemistry (IHC) and a loss of MLH1, MSH2, MSH6 or PMS2 was assigned as high microsatellite instability (MSI-H), while low microsatellite instability (MSI-L) was defined as MGMT IHC negativity only </plain></SENT>
<SENT sid="5" pm="."><plain>CIN was detected in 78% of <z:hpo ids='HP_0000001'>all</z:hpo> MSI-H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, most commonly as a gain of chromosome 8 </plain></SENT>
<SENT sid="6" pm="."><plain>Methylation data analyses allowed classification of samples into four groups and detected similar methylation profiles in SSA/P and MSI-H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>TSA also revealed aberrant methylation pattern, but clustered more heterogeneously and closer to microsatellite stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>SSA/P, TSA and MSI-H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> had the highest degree of promotor methylation (CIMP pathway) </plain></SENT>
<SENT sid="9" pm="."><plain><z:mp ids='MP_0008866'>Chromosomal instability</z:mp>, in contrast to the established doctrine, is a common phenomenon in MSI <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, yet to a lower extent and at later stages than in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Methylation analyses suggest that SSA/P are precursors for MSI-H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> and follow the CIMP pathway </plain></SENT>
</text></document>